CORE LABORATORIES INC (CLB)
US21867A1051 - Common Stock
Core Laboratories (CLB) Q2 2024 Earnings Call Transcript
CLB earnings call for the period ending June 30, 2024.
CLB Stock Earnings: Core Laboratories Beats EPS, Misses Revenue for Q2 2024
CLB stock results show that Core Laboratories beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
CLB Stock Earnings: Core Laboratories Beats EPS, Misses Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Core Laboratories (NYSE:CLB) just reported results for the second quarter of 20...
Gateway Group Announces Preliminary Sponsors and Additional Presenting Companies for September Gateway Conference
Executives from a Range of Industries to Present to 300+ Institutional Investors and Analysts in San Francisco on September 4-5, 2024
CLB Stock Earnings: Core Laboratories Beats EPS, Beats Revenue for Q1 2024
CLB stock results show that Core Laboratories beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
CLB Stock Earnings: Core Laboratories Beats EPS, Beats Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Core Laboratories (NYSE:CLB) just reported results for the first quarter of 202...
Core Laboratories (CLB) Q4 2023 Earnings Call Transcript
CLB earnings call for the period ending December 31, 2023.
Commit To Purchase Core Laboratories At $15, Earn 15.7% Annualized Using Options
Noteworthy Thursday Option Activity: BMRN, CLB, PARA
February Risk Alert: 3 Stocks to Unload Now to Protect Your Portfolio
Discover the hidden pitfalls in the investment world with a deep dive into these three stocks to sell now to protect your portfolio.
3 Oil Stocks to Sell in January Before They Crash and Burn
You have until the end of the month to dump these oil stocks before they crash. Do you have these three in your portfolio?
Noteworthy Tuesday Option Activity: BMBL, TOL, CLB
Core Laboratories is Now Oversold (CLB)
Core Laboratories (CLB) Q3 2023 Earnings Call Transcript
CLB earnings call for the period ending September 30, 2023.
Core Laboratories declares $0.01 dividend (NYSE:CLB)
Core Laboratories (CLB) declares $0.01/share quarterly dividend, in line with previous. Forward yield 0.19% Payable Dec. 4; for shareholders of record Nov. 13;
Commit To Buy Core Laboratories At $17.50, Earn 12.5% Annualized Using Options
Halliburton, Core Labs team up to accelerate digital rock data solutions (NYSE:CLB)
Halliburton and Core Laboratories collaborate to accelerate delivery of digital rock data solutions "from months to weeks," driving accuracy and innovation in the oil industry.
CORE LABORATORIES AND HALLIBURTON ANNOUNCE COLLABORATION TO INTEGRATE DIGITAL ROCK CAPABILITIES WITH LABORATORY MEASURED DATA
/PRNewswire/ -- Halliburton Company (NYSE: HAL) and Core Laboratories Inc. (NYSE: CLB) today announced a strategic collaboration in the U.S. to compress the...
Noteworthy Thursday Option Activity: CLB, WW, CRC
Noteworthy Wednesday Option Activity: CVNA, CLB, SEAS
Commit To Purchase Core Laboratories At $17.50, Earn 9.4% Annualized Using Options
Core Laboratories (CLB) Q2 2023 Earnings Call Transcript
CLB earnings call for the period ending June 30, 2023.
(NYSE:CLB)
Core Laboratories press release (CLB): Q2 GAAP EPS of $0.48 beats by $0.27.Revenue of $127.9M (+5.8% Y/Y) misses by $4.15M.
Core Labs slashed to Sell at Citi on North America completion weakness (NYSE:CLB)
Core Laboratories (CLB) is downgraded to Sell with a $21 price target at Citi, after the oilfield services company has gained more than 20% YTD and outperformed similar-sized peers.
Core Laboratories (CLB) Q1 2023 Earnings Call Transcript
CLB earnings call for the period ending March 31, 2023.
(NYSE:CLB)
Core Laboratories press release (CLB): Q1 GAAP EPS of $0.05 misses by $0.10.Revenue of $128M (+11.0% Y/Y) beats by $2.08M.OPERATING INCOME OF $6.5 MILLION; EX-ITEMS OF $14.5...